Exposure to phthalates, prevalent in plastics, is linked to over 356,000 heart disease deaths globally in 2018, according to a new NYU Langone Health study. The research highlights urgent calls for stricter global regulations, particularly in rapidly industrializing regions with rising plastic use and limited controls.

A Canadian Journal of Cardiology study reveals that 40-63% of sudden cardiac arrest cases could be prevented through lifestyle changes, identifying 56 risk factors. The research underscores the need for public awareness campaigns focusing on lifestyle interventions and highlights the complex interplay of genetic and lifestyle factors.

A Memorial Sloan Kettering study shows the immunotherapy drug dostarlimab may help early-stage cancer patients avoid surgery, with 92% showing no disease signs after two years. The promising results, especially for those with mismatch repair defects, are pushing further trials and FDA fast tracking, though careful monitoring is essential due to potential side effects.

The Global Virus Network (GVN) warns of the rising threat of H5N1 avian influenza, urging enhanced surveillance amid over 70 human cases in the US, including a confirmed death. Experts stress the importance of biosecurity and public education as mutations could heighten pandemic risks.

North Carolina State University unveils a breakthrough in soft robotics with a light-powered robot that autonomously transports cargo along aerial tracks. This innovation, published in Advanced Science, can navigate steep slopes and carry loads 12 times its weight without motors, offering potential applications in agriculture and disaster relief.

A new study in Molecular Psychiatry reveals prenatal stress can molecularly alter newborns' stress response systems, with notable sex differences. Girls showed reduced acetylcholine production, while boys had increased enzyme levels breaking it down, emphasizing maternal mental health's importance.

Metabolon, Inc. has launched an advanced microbiome research solution combining metagenomics, metabolomics, and bioinformatics for enhanced insights. This integration offers researchers a deeper understanding of microbial functions and disease progression, leveraging 25 years of expertise and a vast metabolomics library.

The FDA has approved ZEVASKYN, the first cell-based gene therapy for recessive dystrophic epidermolysis bullosa, revolutionizing treatment for this severe skin condition. Abeona Therapeutics will discuss this landmark development and future plans in a conference call today.

Microba Life Sciences Limited's MetaPanel™ test identifies gastrointestinal pathogens in over 35% of IBD patients experiencing flares, a significant improvement over current tests. Partnering with the Colonoscopy Clinic, Microba aims to integrate this advanced diagnostics into routine care, potentially transforming IBD management for millions globally.

Microbiotica's MB097, a gut bacteria-based therapy, shows promise in boosting immunotherapy effectiveness for advanced melanoma patients. New data was unveiled at the AACR Annual Meeting, with Phase 1b trial results expected by late 2025.

Dell Medical School has discovered that low-intensity focused ultrasound treatment significantly eases depression, anxiety, and PTSD symptoms. The non-invasive method, targeting the amygdala, showed immediate benefits without adverse effects, offering hope for those unresponsive to traditional therapies.

The University of Adelaide introduces dFLASH, a revolutionary technology poised to transform drug and genomics screening, accelerating the discovery of new therapeutic targets. This advancement promises significant impacts on treatments for cancer, metabolic diseases, and more, as reported in Nature Communications.

FIFA funds a pivotal study at Kingston University starting May 2025, targeting hormonal influences on ACL injuries in women's soccer. The research aims to create tailored training to curb injury risks linked to menstrual cycles, a response to the higher ACL injury rates in female athletes.

Columbia Engineering has unveiled a powerful AI algorithm that can deduce the atomic structure of nanocrystals from diffraction patterns with unprecedented accuracy. This breakthrough in crystallography could transform industries like pharmaceuticals and energy by allowing for detailed analysis of materials previously too challenging to study.

A study reveals 56 non-clinical risk factors for sudden cardiac arrest, suggesting lifestyle changes could prevent up to 63% of cases. The research highlights unexpected benefits of champagne and white wine, challenging the traditional focus on red wine's cardioprotective effects.

A team led by Professor Chen-Sheng Yeh at National Cheng Kung University has created a groundbreaking cancer detection method using gold nanoparticles, enhancing sensitivity without fluorescent dyes. This approach, which has shown remarkable success in early trials, is being developed into diagnostic products through collaborations with biotech firms, with patents pending in the U.S. and Taiwan.

Washington University researchers have developed a neural decoder to restore communication between the brain and spinal cord, potentially revolutionizing spinal cord injury rehabilitation. This noninvasive system, achieving up to 83% accuracy, could enhance voluntary movement and reduce rehabilitation costs, emphasizing regulatory updates for evolving tech.

A study in Nature Communications reveals ancient genes can convert mouse cells into pluripotent stem cells, challenging existing stem cell biology beliefs. Led by HKUMed and others, the research highlights the evolutionary significance of these genes, opening new therapeutic possibilities.

Stewart Mallory's research at Penn State advances our understanding of self-propelled microscopic particles, especially regarding their behavior in confined spaces. His work has significant implications for drug delivery and environmental cleanup, as it explores the potential of using microscopic robots and nanoparticles to target cancer cells and break down pollutants.